The invention relates to a fluorescent quantitative PCR (
Polymerase Chain Reaction) diagnosis kit for detecting mRNA of an M BCR
fusion gene, belonging to the field of
biotechnology. The kit comprises a detection primer, a fluorescent probe, a cDNA first-chain synthesis
reagent, a fluorescent quantitative PCR mixed liquor,
negative control and
positive control, wherein the detection primer and the fluorescent probe comprise an M BCR
gene primer, a
reference gene ABL primer and a
Taqman fluorescent probe. The kit can effectively detect the M BCR
fusion gene forms, such as e14a3, e13a3, e14a2 and e13a2. The M BCR
fusion gene is a
gene mark of malignant clone of pluripotential hemopoietic stem cells, is a typical
molecular marker of
chronic granulocytic leukemia and is related to inhibition of the
apoptosis of the leukemic
cell. The fluorescent quantitative PCR technology with higher sensitivity and specificity is used for detecting the
mRNA level of the M BCR
gene, and the specificity and the sensitivity of the detection result both are improved remarkably. The kit provided by the invention provides a brand-new rapid, simple and convenient gene diagnosis technology for making a therapeutic
regimen for the patients with
chronic granulocytic leukemia, and predicting prognosis.